Editor’s note

Time for a new strategy?

Read more

Who’s next, after Torrent-Unichem?

Read more

Converting growth potential into a reality

Read more

Balancing volumes with value

Read more

What ails India’s pharma exports?

Read more

A double whammy for the sector?

Read more

Draft pharma policy: Old wine in a new bottle?

Read more

Surviving serialisation

Read more

India Pharma Inc’s tryst with destiny continues

Read more

A wake up call for serialisation laggards

Read more